Some geometric methods for constructing decision criteria based on two-dimensional parameters

Journal of Statistical Planning and Inference

Volumn 138, Issue 2, 2008, Pages 516-527

  Thall, Peter F ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Bayesian statistics; Clinical trials; Dose finding; Indifference set; Medical decision making; Phase II clinical trial; Trade offs

Indexed keywords

EID: 35348891441     PISSN: 03783758     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jspi.2007.06.013     Document Type: Article

References (15)

1. Bryant J., and Day R. Incorporating toxicity considerations into the design of two-stage phase II clinical trials. Biometrics 51 (1995) 1372-1383
2. Cole B.F., Gelber R.D., and Anderson K.M. Parametric approaches to quality-adjusted survival analysis. Biometrics 50 (1994) 621-631
3. Conaway M.R., and Petroni G.R. Bivariate sequential designs for phase II trials. Biometrics 51 (1995) 656-664
4. p norms. Technical Report UTMDABTR-003-06, Department of Biostatistics, M.D. Anderson Cancer Center.
5. Gelber R.D., Gelman R.S., and Goldhirsch A. A quality-of-life-oriented endpoint for comparing therapies. Biometrics 45 (1989) 781-795
6. Jennison C., and Turnbull B.W. Group sequential tests for bivariate response: interim analyses of clinical trials with both efficacy and safety endpoints. Biometrics 49 (1993) 741-752
7. Jennison C., and Turnbull B.W. Group Sequential Methods with Applications to Clinical Trials (2000), Chapman & Hall, New York
8. Lavori P.W., and Dawson R. Dynamic treatment regimes: practical design considerations. Clinical Trials 1 (2004) 9-20
9. Murphy S.A. Optimal dynamic treatment regimes (with discussion). J. Roy. Statist. Soc. Ser. B 65 (2003) 331-366
10. Thall P.F., and Cheng S.-C. Treatment comparisons based on two-dimensional safety and efficacy alternatives in oncology trials. Biometrics 55 (1999) 746-753
11. Thall P.F., and Cook J.D. Dose-finding based on efficacy-toxicity trade-offs. Biometrics 60 (2004) 684-693
12. Thall P.F., Simon R., and Estey E.H. Bayesian sequential monitoring designs for single-arm clinical trials with multiple outcomes. Statistics in Medicine 14 (1995) 357-379
13. Thall P.F., Sung H.-G., and Estey E.H. Selecting therapeutic strategies based on efficacy and death in multi-course clinical trials. J. Amer. Statist. Assoc. 97 (2002) 29-39
14. Thall P.F., Cook J.D., and Estey E.H. Adaptive dose selection using efficacy-toxicity trade-offs: illustrations and practical considerations. J. Biopharmaceutical Statist. 16 (2006) 623-638
15. Thall P.F., Wooten L.H., and Shpall E.J. A geometric approach to comparing treatments for rapidly fatal diseases. Biometrics 62 (2006) 193-201